| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 672.21× | 672.21× | 246.91× | 204.73× | 919.52× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 16.14× | 16.14× | 17.57× | 18.69× | 19.94× | ||
| 5,95,375.83× | 5,95,375.83× | 26,27,914.12× | 3,18,995.96× | 6,24,858.94× | ||
| −5,94,687.48× | −5,94,687.48× | −26,27,649.64× | −3,18,772.54× | −6,23,919.48× | ||
| −2.56× | −2.52× | −1.77× | −1.03× | −0.91× | ||
| 0.23× | 0.23× | 0.23× | 0.22× | 0.21× | ||
| 0.56× | 0.56× | −0.34× | −0.67× | −0.64× | ||
| 1.02× | 1.02× | 0.51× | 1.22× | 1.12× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Inventory Days (DIO) | 919.52 | 204.73 | 246.91 | 672.21 | 672.21 | |
| Receivable Days (DSO) | 19.94 | 18.69 | 17.57 | 16.14 | 16.14 | |
| Payable Days (DPO) | 6,24,858.94 | 3,18,995.96 | 26,27,914.12 | 5,95,375.83 | 5,95,375.83 | |
| Cash Conversion Cycle (days) | -6,23,919.48 | -3,18,772.54 | -26,27,649.64 | -5,94,687.48 | -5,94,687.48 | |
| Working Capital Turnover | -0.91 | -1.03 | -1.77 | -2.52 | -2.56 | |
| Asset Turnover | 0.21 | 0.22 | 0.23 | 0.23 | 0.23 | |
| Cash Conversion (CFO/Net Income) | -0.64 | -0.67 | -0.34 | 0.56 | 0.56 | |
| CFO/EBITDA | 1.12 | 1.22 | 0.51 | 1.02 | 1.02 |